{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:08:15Z","timestamp":1764047295914,"version":"3.32.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Rutgers University Foundation","award":["#21277"],"award-info":[{"award-number":["#21277"]}]},{"name":"New Jersey Governor\u2019s Council for Medical Research and Treatment of Autism"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The manifestations of tuberous sclerosis complex (TSC) in humans include epilepsy, autism spectrum disorders (ASD) and intellectual disability. Previous studies suggested the linkage of TSC to altered cerebral blood flow and metabolic dysfunction. We previously reported a significant elevation in cerebral blood flow in an animal model of TSC and autism of young Eker rats. Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin could restore normal oxygen consumption and cerebral blood flow. In this study, we investigated whether inhibiting a component of the mTOR signaling pathway, p70 ribosomal S6 kinase (S6K1), would yield comparable effects. Control Long Evans and Eker rats were divided into vehicle and PF-4708671 (S6K1 inhibitor, 75\u00a0mg\/kg for 1\u00a0h) treated groups. Cerebral regional blood flow (<jats:sup>14<\/jats:sup>C-iodoantipyrine) was determined in isoflurane anesthetized rats. We found significantly increased basal cortical (+\u200932%) and hippocampal (+\u200915%) blood flow in the Eker rats. PF-4708671 significantly lowered regional blood flow in the cortex and hippocampus of the Eker rats. PF-4708671 did not significantly lower blood flow in these regions in the control Long Evans rats. Phosphorylation of S6-Ser240\/244 and Akt-Ser473 was moderately decreased in Eker rats but only the latter reached statistical significance upon PF-4708671 treatment. Our findings suggest that moderate inhibition of S6K1 with PF-4708671 helps to restore normal cortical blood flow in Eker rats and that this information might have therapeutic potential in tuberous sclerosis complex and autism.<\/jats:p>","DOI":"10.1007\/s12017-024-08780-7","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T04:02:39Z","timestamp":1712203359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inhibition of p70 Ribosomal S6 Kinase (S6K1) Reduces Cortical Blood Flow in a Rat Model of Autism-Tuberous Sclerosis"],"prefix":"10.1007","volume":"26","author":[{"given":"Oak Z.","family":"Chi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey","family":"Fortus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Werlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela","family":"Jacinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey R.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"issue":"18","key":"8780_CR1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2001681118","volume":"118","author":"S Aryal","year":"2021","unstructured":"Aryal, S., Longo, F., & Klann, E. (2021). Genetic removal of p70 S6K1 corrects coding sequence length-dependent alterations in mRNA translation in fragile X syndrome mice. Proceedings of the National Academy of Sciences of the United States of America, 118(18), e2001681118. https:\/\/doi.org\/10.1073\/pnas.2001681118","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"14","key":"8780_CR2","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.3390\/ijms22147273","volume":"22","author":"D Bassetti","year":"2021","unstructured":"Bassetti, D., Luhmann, H. J., & Kirischuk, S. (2021). Effects of mutations in TSC genes on neurodevelopment and synaptic transmission. International Journal of Molecular Sciences, 22(14), 7273. https:\/\/doi.org\/10.3390\/ijms22147273","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"8780_CR3","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nrd3531","volume":"10","author":"D Benjamin","year":"2011","unstructured":"Benjamin, D., Colombi, M., Moroni, C., & Hall, M. N. (2011). Rapamycin passes the torch: A new generation of mTOR inhibitors. Nature Reviews Drug Discovery, 10(11), 868\u2013880. https:\/\/doi.org\/10.1038\/nrd3531","journal-title":"Nature Reviews Drug Discovery"},{"issue":"8","key":"8780_CR4","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1038\/npp.2015.369","volume":"41","author":"A Bhattacharya","year":"2016","unstructured":"Bhattacharya, A., Mamcarz, M., Mullins, C., Choudhury, A., Boyle, R. G., Smith, D. G., Walker, D. W., & Klann, E. (2016). Targeting translation control with p70 S6 kinase 1 inhibitors to reverse phenotypes in fragile X syndrome mice. Neuropsychopharmacology, 41(8), 1991\u20132000. https:\/\/doi.org\/10.1038\/npp.2015.369","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"8780_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejpn.2009.03.003","volume":"14","author":"R Bombardieri","year":"2010","unstructured":"Bombardieri, R., Pinci, M., Moavero, R., Cerminara, C., & Curatolo, P. (2010). Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. European Journal of Paediatric Neurology, 14(2), 146\u2013149. https:\/\/doi.org\/10.1016\/j.ejpn.2009.03.003","journal-title":"European Journal of Paediatric Neurology"},{"issue":"12","key":"8780_CR6","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1007\/s00381-021-05218-4","volume":"37","author":"S Cavalheiro","year":"2021","unstructured":"Cavalheiro, S., da Costa, M. D. S., & Richtmann, R. (2021). Everolimus as a possible prenatal treatment of in utero diagnosed subependymal lesions in tuberous sclerosis complex: A case report. Child\u2019s Nervous System, 37(12), 3897\u20133899. https:\/\/doi.org\/10.1007\/s00381-021-05218-4","journal-title":"Child\u2019s Nervous System"},{"issue":"3","key":"8780_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12017-015-8359-5","volume":"17","author":"OZ Chi","year":"2015","unstructured":"Chi, O. Z., Wu, C.-C., Liu, X., Rah, K. H., Jacinto, E., & Weiss, H. R. (2015). Restoration of normal cerebral oxygen consumption with rapamycin treatment in a rat model of autism-tuberous sclerosis. Neuromolecular Medicine, 17(3), 305\u2013313. https:\/\/doi.org\/10.1007\/s12017-015-8359-5","journal-title":"Neuromolecular Medicine"},{"key":"8780_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-023-00762-2","author":"P Curatolo","year":"2023","unstructured":"Curatolo, P., Scheper, M., Emberti Gialloreti, L., Specchio, N., & Aronica, E. (2023). Is tuberous sclerosis complex-associated autism a preventable and treatable disorder? World Journal of Pediatrics. https:\/\/doi.org\/10.1007\/s12519-023-00762-2","journal-title":"World Journal of Pediatrics"},{"issue":"9","key":"8780_CR9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S1474-4422(22)00213-7","volume":"21","author":"P Curatolo","year":"2022","unstructured":"Curatolo, P., Specchio, N., & Aronica, E. (2022). Advances in the genetics and neuropathology of tuberous sclerosis complex: Edging closer to targeted therapy. The Lancet Neurology, 21(9), 843\u2013856. https:\/\/doi.org\/10.1016\/S1474-4422(22)00213-7","journal-title":"The Lancet Neurology"},{"issue":"18","key":"8780_CR10","doi-asserted-by":"publisher","first-page":"10058","DOI":"10.3390\/ijms221810058","volume":"22","author":"GA Czapski","year":"2021","unstructured":"Czapski, G. A., Babiec, L., J\u0119\u015bko, H., G\u0105ssowska-Dobrowolska, M., Cie\u015blik, M., Matuszewska, M., Frontczak-Baniewicz, M., Zajdel, K., & Adamczyk, A. (2021). Synaptic alterations in a transgenic model of tuberous sclerosis complex: Relevance to autism spectrum disorders. International Journal of Molecular Sciences, 22(18), 10058. https:\/\/doi.org\/10.3390\/ijms221810058","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"8780_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.nurt.2010.05.001","volume":"7","author":"PJ de Vries","year":"2010","unstructured":"de Vries, P. J. (2010). Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex. Neurotherapeutics, 7(3), 275\u2013282. https:\/\/doi.org\/10.1016\/j.nurt.2010.05.001","journal-title":"Neurotherapeutics"},{"issue":"8","key":"8780_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1788","volume":"14","author":"D Ehninger","year":"2008","unstructured":"Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008). Reversal of learning deficits in a Tsc2+\/- mouse model of tuberous sclerosis. Nature Medicine, 14(8), 843\u2013848. https:\/\/doi.org\/10.1038\/nm1788","journal-title":"Nature Medicine"},{"issue":"12","key":"8780_CR13","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1111\/epi.17099","volume":"62","author":"DN Franz","year":"2021","unstructured":"Franz, D. N., Lawson, J. A., Yapici, Z., Ikeda, H., Polster, T., Nabbout, R., & French, J. A. (2021). Adjunctive everolimus therapy for tuberous sclerosis complex-associated refractory seizures: Results from the postextension phase of EXIST-3. Epilepsia, 62(12), 3029\u20133041. https:\/\/doi.org\/10.1111\/epi.17099","journal-title":"Epilepsia"},{"issue":"10056","key":"8780_CR14","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","volume":"388","author":"JA French","year":"2016","unstructured":"French, J. A., Lawson, J. A., Yapici, Z., Ikeda, H., Polster, T., Nabbout, R., & Franz, D. N. (2016). Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): A phase 3, randomised, double-blind, placebo-controlled study. The Lancet (London, England), 388(10056), 2153\u20132163. https:\/\/doi.org\/10.1016\/S0140-6736(16)31419-2","journal-title":"The Lancet (London, England)"},{"issue":"7","key":"8780_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5483\/BMBRep.2019.52.7.137","volume":"52","author":"H Ganesan","year":"2019","unstructured":"Ganesan, H., Balasubramanian, V., Iyer, M., Venugopal, A., Subramaniam, M. D., Cho, S.-G., & Vellingiri, B. (2019). mTOR signalling pathway: A root cause for idiopathic autism? BMB Reports, 52(7), 424\u2013433. https:\/\/doi.org\/10.5483\/BMBRep.2019.52.7.137","journal-title":"BMB Reports"},{"issue":"4","key":"8780_CR16","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1007\/s11033-023-08283-x","volume":"50","author":"SK Ganesh","year":"2023","unstructured":"Ganesh, S. K., & Subathra Devi, C. (2023). Molecular and therapeutic insights of rapamycin: A multi-faceted drug from Streptomyces hygroscopicus. Molecular Biology Reports, 50(4), 3815\u20133833. https:\/\/doi.org\/10.1007\/s11033-023-08283-x","journal-title":"Molecular Biology Reports"},{"issue":"7432","key":"8780_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature11628","volume":"493","author":"CG Gkogkas","year":"2013","unstructured":"Gkogkas, C. G., Khoutorsky, A., Ran, I., Rampakakis, E., Nevarko, T., Weatherill, D. B., & Sonenberg, N. (2013). Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature, 493(7432), 371\u2013377. https:\/\/doi.org\/10.1038\/nature11628","journal-title":"Nature"},{"key":"8780_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/978-1-4419-6448-9_8","volume":"685","author":"SL Habib","year":"2010","unstructured":"Habib, S. L. (2010). Tuberous sclerosis complex and DNA repair. Advances in Experimental Medicine and Biology, 685, 84\u201394. https:\/\/doi.org\/10.1007\/978-1-4419-6448-9_8","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"8780_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tibs.2004.11.003","volume":"30","author":"LS Harrington","year":"2005","unstructured":"Harrington, L. S., Findlay, G. M., & Lamb, R. F. (2005). Restraining PI3K: MTOR signalling goes back to the membrane. Trends in Biochemical Sciences, 30(1), 35\u201342. https:\/\/doi.org\/10.1016\/j.tibs.2004.11.003","journal-title":"Trends in Biochemical Sciences"},{"issue":"6","key":"8780_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/fcp.12216","volume":"30","author":"I Hayashi","year":"2016","unstructured":"Hayashi, I., Aoki, Y., Ushikubo, H., Asano, D., Mori, A., Sakamoto, K., Nakahara, T., & Ishii, K. (2016). Protective effects of PF-4708671 against N-methyl-d-aspartic acid-induced retinal damage in rats. Fundamental & Clinical Pharmacology, 30(6), 529\u2013536. https:\/\/doi.org\/10.1111\/fcp.12216","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"8780_CR21","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"EP Henske","year":"2016","unstructured":"Henske, E. P., J\u00f3\u017awiak, S., Kingswood, J. C., Sampson, J. R., & Thiele, E. A. (2016). Tuberous sclerosis complex. Nature Reviews Disease Primers, 2, 16035. https:\/\/doi.org\/10.1038\/nrdp.2016.35","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"8780_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/bjo.87.1.96","volume":"87","author":"SL Hosking","year":"2003","unstructured":"Hosking, S. L., Roff Hilton, E. J., Embleton, S. J., & Gupta, A. K. (2003). Epilepsy patients treated with vigabatrin exhibit reduced ocular blood flow. The British Journal of Ophthalmology, 87(1), 96\u2013100. https:\/\/doi.org\/10.1136\/bjo.87.1.96","journal-title":"The British Journal of Ophthalmology"},{"issue":"2","key":"8780_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang, J., & Manning, B. D. (2008). The TSC1-TSC2 complex: A molecular switchboard controlling cell growth. The Biochemical Journal, 412(2), 179\u2013190. https:\/\/doi.org\/10.1042\/BJ20080281","journal-title":"The Biochemical Journal"},{"issue":"3","key":"8780_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cell.2008.10.017","volume":"135","author":"RJ Kelleher","year":"2008","unstructured":"Kelleher, R. J., & Bear, M. F. (2008). The autistic neuron: Troubled translation? Cell, 135(3), 401\u2013406. https:\/\/doi.org\/10.1016\/j.cell.2008.10.017","journal-title":"Cell"},{"key":"8780_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109203","volume":"218","author":"M Koike-Kumagai","year":"2022","unstructured":"Koike-Kumagai, M., Fujimoto, M., & Wataya-Kaneda, M. (2022). Sirolimus relieves seizures and neuropsychiatric symptoms via changes of microglial polarity in tuberous sclerosis complex model mice. Neuropharmacology, 218, 109203. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109203","journal-title":"Neuropharmacology"},{"issue":"6","key":"8780_CR26","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.ejpn.2018.06.007","volume":"22","author":"Krueger, D. A., Capal, J. K., Curatolo, P., Devinsky, O., Ess, K., Tzadok, M., \u2026 & TSCure Research Group","year":"2018","unstructured":"Krueger, D. A., Capal, J. K., Curatolo, P., Devinsky, O., Ess, K., Tzadok, M., \u2026 & TSCure Research Group. (2018). Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience. European Journal of Paediatric Neurology, 22(6), 1066\u20131073. https:\/\/doi.org\/10.1016\/j.ejpn.2018.06.007","journal-title":"European Journal of Paediatric Neurology"},{"issue":"1","key":"8780_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13311-019-00812-6","volume":"17","author":"V K\u00fatna","year":"2020","unstructured":"K\u00fatna, V., Uttl, L., Waltereit, R., Kri\u0161tofikov\u00e1, Z., Kaping, D., Petr\u00e1sek, T., Hoschl, C., & Ovsepian, S. V. (2020). Tuberous sclerosis (tsc2+\/-) model Eker rats reveals extensive neuronal loss with microglial invasion and vascular remodeling related to brain neoplasia. Neurotherapeutics, 17(1), 329\u2013339. https:\/\/doi.org\/10.1007\/s13311-019-00812-6","journal-title":"Neurotherapeutics"},{"issue":"3","key":"8780_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","volume":"19","author":"J Li","year":"2014","unstructured":"Li, J., Kim, S. G., & Blenis, J. (2014). Rapamycin: One drug, many effects. Cell Metabolism, 19(3), 373\u2013379. https:\/\/doi.org\/10.1016\/j.cmet.2014.01.001","journal-title":"Cell Metabolism"},{"issue":"12","key":"8780_CR29","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3390\/cells8121584","volume":"8","author":"C Magaway","year":"2019","unstructured":"Magaway, C., Kim, E., & Jacinto, E. (2019). Targeting mTOR and metabolism in cancer: Lessons and innovations. Cells, 8(12), 1584. https:\/\/doi.org\/10.3390\/cells8121584","journal-title":"Cells"},{"issue":"13","key":"8780_CR30","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.3390\/ijms22136677","volume":"22","author":"M Mizuguchi","year":"2021","unstructured":"Mizuguchi, M., Ohsawa, M., Kashii, H., & Sato, A. (2021). Brain symptoms of tuberous sclerosis complex: Pathogenesis and treatment. International Journal of Molecular Sciences, 22(13), 6677. https:\/\/doi.org\/10.3390\/ijms22136677","journal-title":"International Journal of Molecular Sciences"},{"issue":"14","key":"8780_CR31","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.4161\/cc.10.14.16586","volume":"10","author":"WJ Oh","year":"2011","unstructured":"Oh, W. J., & Jacinto, E. (2011). mTOR complex 2 signaling and functions. Cell Cycle, 10(14), 2305\u20132316. https:\/\/doi.org\/10.4161\/cc.10.14.16586","journal-title":"Cell Cycle"},{"issue":"1","key":"8780_CR32","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1038\/s41467-021-26131-z","volume":"12","author":"M Pagani","year":"2021","unstructured":"Pagani, M., Barsotti, N., Bertero, A., Trakoshis, S., Ulysse, L., Locarno, A., & Gozzi, A. (2021). mTOR-related synaptic pathology causes autism spectrum disorder-associated functional hyperconnectivity. Nature Communications, 12(1), 6084. https:\/\/doi.org\/10.1038\/s41467-021-26131-z","journal-title":"Nature Communications"},{"issue":"2","key":"8780_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1042\/BJ20101024","volume":"431","author":"LR Pearce","year":"2010","unstructured":"Pearce, L. R., Alton, G. R., Richter, D. T., Kath, J. C., Lingardo, L., Chapman, J., Hwang, C., & Alessi, D. R. (2010). Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). The Biochemical Journal, 431(2), 245\u2013255. https:\/\/doi.org\/10.1042\/BJ20101024","journal-title":"The Biochemical Journal"},{"key":"8780_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2018.10.005","volume":"90","author":"JM Peters","year":"2019","unstructured":"Peters, J. M., Prohl, A., Kapur, K., Nath, A., Scherrer, B., Clancy, S., Prabhu, S. P., Sahin, M., Franz, D. N., Warfield, S. K., & Krueger, D. A. (2019). Longitudinal effects of everolimus on white matter diffusion in tuberous sclerosis complex. Pediatric Neurology, 90, 24\u201330. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2018.10.005","journal-title":"Pediatric Neurology"},{"issue":"5","key":"8780_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2217\/fnl.13.37","volume":"8","author":"JM Peters","year":"2013","unstructured":"Peters, J. M., Taquet, M., Prohl, A. K., Scherrer, B., Van Eeghen, A. M., Prabhu, S. P., Sahin, M., & Warfield, S. K. (2013). Diffusion tensor imaging and related techniques in tuberous sclerosis complex: Review and future directions. Future Neurology, 8(5), 583\u2013597. https:\/\/doi.org\/10.2217\/fnl.13.37","journal-title":"Future Neurology"},{"issue":"5","key":"8780_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1034\/j.1601-183x.2003.00037.x","volume":"2","author":"JLR Rubenstein","year":"2003","unstructured":"Rubenstein, J. L. R., & Merzenich, M. M. (2003). Model of autism: Increased ratio of excitation\/inhibition in key neural systems. Genes, Brain, and Behavior, 2(5), 255\u2013267. https:\/\/doi.org\/10.1034\/j.1601-183x.2003.00037.x","journal-title":"Genes, Brain, and Behavior"},{"issue":"1","key":"8780_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00330-022-09036-3","volume":"33","author":"C Rutten","year":"2023","unstructured":"Rutten, C., Fillon, L., Kuchenbuch, M., Saitovitch, A., Boisgontier, J., Chemaly, N., & Boddaert, N. (2023). The longitudinal evolution of cerebral blood flow in children with tuberous sclerosis assessed by arterial spin labeling magnetic resonance imaging may be related to cognitive performance. European Radiology, 33(1), 196\u2013206. https:\/\/doi.org\/10.1007\/s00330-022-09036-3","journal-title":"European Radiology"},{"issue":"2","key":"8780_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","volume":"22","author":"DD Sarbassov","year":"2006","unstructured":"Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006). Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB. Molecular Cell, 22(2), 159\u2013168. https:\/\/doi.org\/10.1016\/j.molcel.2006.03.029","journal-title":"Molecular Cell"},{"issue":"5","key":"8780_CR39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00406-016-0703-8","volume":"267","author":"M Schneider","year":"2017","unstructured":"Schneider, M., de Vries, P. J., Sch\u00f6nig, K., R\u00f6\u00dfner, V., & Waltereit, R. (2017). mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus. European Archives of Psychiatry and Clinical Neuroscience, 267(5), 455\u2013463. https:\/\/doi.org\/10.1007\/s00406-016-0703-8","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"8780_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105067","volume":"147","author":"A Sharma","year":"2021","unstructured":"Sharma, A., & Mehan, S. (2021). Targeting PI3K-AKT\/mTOR signaling in the prevention of autism. Neurochemistry International, 147, 105067. https:\/\/doi.org\/10.1016\/j.neuint.2021.105067","journal-title":"Neurochemistry International"},{"issue":"7","key":"8780_CR41","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1212\/wnl.53.7.1518","volume":"53","author":"MV Spanaki","year":"1999","unstructured":"Spanaki, M. V., Siegel, H., Kopylev, L., Fazilat, S., Dean, A., Liow, K., Ben-Menachem, E., Gaillard, W. D., & Theodore, W. H. (1999). The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism. Neurology, 53(7), 1518\u20131522. https:\/\/doi.org\/10.1212\/wnl.53.7.1518","journal-title":"Neurology"},{"key":"8780_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejpn.2023.08.005","volume":"47","author":"N Specchio","year":"2023","unstructured":"Specchio, N., Nabbout, R., Aronica, E., Auvin, S., Benvenuto, A., de Palma, L., & Curatolo, P. (2023). Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy. European Journal of Paediatric Neurology, 47, 25\u201334. https:\/\/doi.org\/10.1016\/j.ejpn.2023.08.005","journal-title":"European Journal of Paediatric Neurology"},{"key":"8780_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.nbd.2015.10.001","volume":"85","author":"IN Srivastava","year":"2016","unstructured":"Srivastava, I. N., Shperdheja, J., Baybis, M., Ferguson, T., & Crino, P. B. (2016). mTOR pathway inhibition prevents neuroinflammation and neuronal death in a mouse model of cerebral palsy. Neurobiology of Disease, 85, 144\u2013154. https:\/\/doi.org\/10.1016\/j.nbd.2015.10.001","journal-title":"Neurobiology of Disease"},{"issue":"3","key":"8780_CR44","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","volume":"101","author":"A Szwed","year":"2021","unstructured":"Szwed, A., Kim, E., & Jacinto, E. (2021). Regulation and metabolic functions of mTORC1 and mTORC2. Physiological Reviews, 101(3), 1371\u20131426. https:\/\/doi.org\/10.1152\/physrev.00026.2020","journal-title":"Physiological Reviews"},{"issue":"4","key":"8780_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ana.22696","volume":"71","author":"DM Talos","year":"2012","unstructured":"Talos, D. M., Sun, H., Kosaras, B., Joseph, A., Folkerth, R. D., Poduri, A., Madsen, J. R., Black, P. M., & Jensen, F. E. (2012). Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. Annals of Neurology, 71(4), 539\u2013551. https:\/\/doi.org\/10.1002\/ana.22696","journal-title":"Annals of Neurology"},{"key":"8780_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2015.03.001","volume":"131","author":"MR Tavares","year":"2015","unstructured":"Tavares, M. R., Pavan, I. C. B., Amaral, C. L., Meneguello, L., Luchessi, A. D., & Simabuco, F. M. (2015). The S6K protein family in health and disease. Life Sciences, 131, 1\u201310. https:\/\/doi.org\/10.1016\/j.lfs.2015.03.001","journal-title":"Life Sciences"},{"issue":"7413","key":"8780_CR47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nature11310","volume":"488","author":"PT Tsai","year":"2012","unstructured":"Tsai, P. T., Hull, C., Chu, Y., Greene-Colozzi, E., Sadowski, A. R., Leech, J. M., Steinberg, J., Crawley, J. N., Regehr, W. G., & Sahin, M. (2012). Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature, 488(7413), 647\u2013651. https:\/\/doi.org\/10.1038\/nature11310","journal-title":"Nature"},{"issue":"3","key":"8780_CR48","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s10519-010-9399-0","volume":"41","author":"R Waltereit","year":"2011","unstructured":"Waltereit, R., Japs, B., Schneider, M., de Vries, P. J., & Bartsch, D. (2011). Epilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in rats. Behavior Genetics, 41(3), 364\u2013372. https:\/\/doi.org\/10.1007\/s10519-010-9399-0","journal-title":"Behavior Genetics"},{"issue":"5","key":"8780_CR49","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ijdevneu.2008.01.002","volume":"26","author":"HR Weiss","year":"2008","unstructured":"Weiss, H. R., Liu, X., & Chi, O. Z. (2008). Cerebral O(2) consumption in young Eker rats, effects of GABA blockade: Implications for autism. International Journal of Developmental Neuroscience, 26(5), 517\u2013521. https:\/\/doi.org\/10.1016\/j.ijdevneu.2008.01.002","journal-title":"International Journal of Developmental Neuroscience"},{"issue":"5","key":"8780_CR50","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuropharm.2012.06.014","volume":"63","author":"HR Weiss","year":"2012","unstructured":"Weiss, H. R., Liu, X., Grewal, P., & Chi, O. Z. (2012). Reduced effect of stimulation of AMPA receptors on cerebral O2 consumption in a rat model of autism. Neuropharmacology, 63(5), 837\u2013841. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.06.014","journal-title":"Neuropharmacology"},{"key":"8780_CR51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.brainres.2009.08.022","volume":"1294","author":"HR Weiss","year":"2009","unstructured":"Weiss, H. R., Liu, X., Hunter, C., & Chi, O. Z. (2009). Effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor blockade on increased cerebral O(2) consumption in Eker rats. Brain Research, 1294, 138\u2013143. https:\/\/doi.org\/10.1016\/j.brainres.2009.08.022","journal-title":"Brain Research"},{"issue":"11","key":"8780_CR52","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/jnr.21378","volume":"85","author":"HR Weiss","year":"2007","unstructured":"Weiss, H. R., Liu, X., Zhang, Q., & Chi, O. Z. (2007). Increased cerebral oxygen consumption in Eker rats and effects of N-methyl-D-aspartate blockade: Implications for autism. Journal of Neuroscience Research, 85(11), 2512\u20132517. https:\/\/doi.org\/10.1002\/jnr.21378","journal-title":"Journal of Neuroscience Research"},{"issue":"2","key":"8780_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-004-0865-8","volume":"108","author":"HJ Wenzel","year":"2004","unstructured":"Wenzel, H. J., Patel, L. S., Robbins, C. A., Emmi, A., Yeung, R. S., & Schwartzkroin, P. A. (2004). Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis. Acta Neuropathologica, 108(2), 97\u2013108. https:\/\/doi.org\/10.1007\/s00401-004-0865-8","journal-title":"Acta Neuropathologica"},{"key":"8780_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-neuro-080317-061747","volume":"41","author":"KD Winden","year":"2018","unstructured":"Winden, K. D., Ebrahimi-Fakhari, D., & Sahin, M. (2018). Abnormal mTOR activation in autism. Annual Review of Neuroscience, 41, 1\u201323. https:\/\/doi.org\/10.1146\/annurev-neuro-080317-061747","journal-title":"Annual Review of Neuroscience"},{"issue":"4","key":"8780_CR55","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ana.21331","volume":"63","author":"L-H Zeng","year":"2008","unstructured":"Zeng, L.-H., Xu, L., Gutmann, D. H., & Wong, M. (2008). Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Annals of Neurology, 63(4), 444\u2013453. https:\/\/doi.org\/10.1002\/ana.21331","journal-title":"Annals of Neurology"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-024-08780-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12017-024-08780-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-024-08780-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T15:49:16Z","timestamp":1735660156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12017-024-08780-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8780"],"URL":"https:\/\/doi.org\/10.1007\/s12017-024-08780-7","relation":{},"ISSN":["1559-1174"],"issn-type":[{"type":"electronic","value":"1559-1174"}],"subject":[],"published":{"date-parts":[[2024,4,4]]},"assertion":[{"value":"4 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial nor other competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"10"}}